Arnold & Itkin Wins $604M Against C.H. Robinson in First Post-Montgomery Freight-Broker Verdict
Arnold & Itkin's $604 million verdict against C.H. Robinson Worldwide Inc., handed down in Dallas County District Court on July 23, 2026, is the first major jury award against a freight broker under the SCOTUS 2024 ruling in Montgomery v. Caribe Transport. The March 2021 crash on Interstate 20 in Mississippi killed three people and injured two. The jury found C.H. Robinson primarily liable for engaging Lupus Superior Trucking despite active FMCSA safety alerts flagging the carrier before hire.
Lead counsel Roland Christensen, Caj Boatright, Alec Paradowski, and Jonathan Mack of Arnold & Itkin tried the case alongside local counsel Chris Simmons and Stephen Higdon of Lyons & Simmons. All three defendants were found negligent: broker, carrier, and driver, with C.H. Robinson bearing the dominant share. The Montgomery framework now permits negligent carrier-selection claims against freight brokers in federal and state courts nationwide, and C.H. Robinson's FMCSA-alert paper trail is the fact pattern plaintiff counsel will replicate in discovery across the trucking-PI docket.
The core discovery target in any post-verdict freight-broker file is the carrier vetting record: pull histories from safety databases, internal compliance checklists, on-boarding deviation logs, and any document showing continued broker use of a flagged carrier after a safety alert issued.
Every freight-broker defendant in a trucking PI file should be evaluated against the carrier safety-alert record at the time of hire; that document set anchors the post-Montgomery liability theory.
Amazon Stipulates Mid-Trial; Middlesex Jury Returns Record $56M in Carnwath
The July 27, 2026 verdict in Carnwath v. Amazon Logistics Inc. / Agora Logistics LLC produced a $56 million award in Middlesex Superior Court, the largest single-plaintiff PI verdict in Massachusetts history and the largest Amazon verdict recorded nationwide. Lead counsel Marc Breakstone of Breakstone, White & Gluck and J. Tucker Merrigan of Sweeney Merrigan Law LLP represented plaintiff Malcolm Carnwath, 78, who suffered a traumatic brain injury, multiple strokes, leg amputation, and requires continuous nursing care following a 2024 head-on collision in New Hampshire.
Amazon stipulated liability mid-trial, abandoning its independent-contractor defense as to delivery subcontractor Agora Logistics before the jury reached the question. Amazon's prior posture consistently treated subcontractor independence as a complete shield; the Carnwath stipulation signals that calculus has shifted, at least on catastrophic, well-documented injury facts involving an elderly plaintiff. The Phoenix federal jury's $8.5 million Uber award on February 5, 2026, recognizing drivers as apparent agents, reinforces the same trajectory across gig-economy platforms.
The Carnwath mid-trial stipulation is the clearest evidence yet that Amazon's delivery-subcontractor liability defense is eroding under catastrophic-injury fact patterns and sustained plaintiff pressure at trial.
Depo-Provera MDL-3140 Daubert Proceeds With 2,100 Non-Settling Plaintiffs at Stake
Judge M. Casey Rodgers in the Northern District of Florida held the general causation Daubert hearing in In re Depo-Provera (Medroxyprogesterone Acetate) Product Liability Litigation, MDL-3140, on July 27, 2026 in Pensacola, notwithstanding Pfizer's tentative global settlement announced June 15, 2026. That deal covers roughly 3,400 of the 5,508 pending plaintiffs, with compensation terms sealed. Judge Rodgers confirmed the hearing would proceed because the agreement will not resolve all cases, leaving approximately 2,100 plaintiffs whose fate turns entirely on the causation ruling.
Both sides fielded five general-causation experts. Plaintiffs moved to exclude Pfizer's defense experts on the ground they improperly minimized the biological connection between prolonged Depo-Provera exposure and meningioma formation. A ruling sustaining plaintiffs' causation theory sustains the remaining MDL pipeline and influences hormonal contraceptive product liability doctrine nationally; an adverse ruling forecloses non-settling plaintiffs' path to trial. Mass-tort firms representing non-settling plaintiffs should prepare supplemental expert disclosures and audit case profiles against the causation evidence before the ruling issues.
MDL-3140's causation ruling is the single most consequential mass-tort decision pending for the plaintiff PI bar this quarter; 2,100 non-settling plaintiffs have no viable litigation path if general causation fails.
Sanders Aronova Lead-Fraud Suit Against Elite Accident Help Sets Vendor-Contract Benchmark
Sanders Aronova Grossman Woycik Viener and Kalant filed suit in the Southern District of New York on July 21, 2026 against Elite Accident Help Corp., seeking recovery of $1.8 million paid for PI lead generation the firm characterizes as fraudulent. The complaint documents eight months of vendor performance collapse: $300,000 per month from September 2025 through April 2026; 204 of 265 leads rejected (77% overall rejection rate); quality deteriorating from 62% qualified at inception to 15% qualified by March 2026; only 61 suits filed; and four settlements generated from the entire vendor relationship.
The fraud theory carries a procedural purpose beyond the damages sought. By alleging fraud rather than breach of contract, Sanders Aronova argues the mandatory arbitration clause is void, keeping the dispute in federal court where the performance data becomes public record. Arbitration-confined vendor disputes tend to produce confidential outcomes that suppress market information about lead quality deterioration patterns precisely like the one documented here.
Every PI firm operator running third-party lead generation at scale should benchmark the Sanders Aronova data. A 77% rejection rate over eight months, visible as a deteriorating quality curve in monthly reporting, is precisely the metric that performance contracts should require vendors to disclose. Operators without written performance floors, monthly rejection-rate reporting, and cure periods carry the same structural exposure now being litigated at $1.8 million.
The Elite Accident Help filing creates a concrete vendor-contract benchmark: demand written performance floors, monthly rejection audits, and explicit fraud carve-outs from mandatory arbitration in every PI lead-generation agreement.
Synergy Launches CONNEXION Lien Portal; Medical Providers Should Map Referring Firm Networks
Synergy Settlement Services launched the CONNEXION unified digital portal on July 23, 2026, consolidating lien resolution, Medicare Secondary Payer compliance, public benefit preservation, attorney fee tax deferral, and real-time case collaboration into a single platform covering all 50 states. CEO Omar Quddus described the platform as a means of eliminating lien management as an administrative drag on counsel, positioning CONNEXION as the operational layer between plaintiff firms and the full lien-resolution workflow.
For medical providers evaluating attorney referral networks, the practical question is which referring firms use a structured lien platform and which do not. Firms on CONNEXION carry real-time status visibility on every open lien, reducing the documentation-gap cycles that delay provider payment post-settlement. The MSP compliance module is especially relevant for providers whose patients are Medicare beneficiaries, a structurally growing share of the PI caseload as the population ages into coverage.
The CONNEXION launch also signals consolidation in lien-tech vendor offerings. Full-stack platforms bundling MSP compliance, benefit preservation, and fee deferral create switching costs that reinforce provider-firm relationships already built around integrated workflows. Medical providers who have not mapped which referring attorney firms use which lien platform are working with incomplete referral-network data as of July 2026.
Medical providers evaluating attorney referral networks should ask each firm which lien-resolution platform they use and whether MSP tracking is real-time; no universal disclosure standard yet governs that question.